Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
20%
Ph phase_3
12
80%

Phase Distribution

0

Early Stage

0

Mid Stage

15

Late Stage

Phase Distribution15 total trials
Phase 3Large-scale testing
12(80.0%)
Phase 4Post-market surveillance
3(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(15)

Detailed Status

Completed15

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 312 (80.0%)
Phase 43 (20.0%)

Trials by Status

completed15100%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
DRUG
Total Trials
15